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ABSTRACT
Health Outcomes Associated with Gulf War Illness
Shannon K. Barth
Background and objectives:
Nearly thirty years after the 1990-1991 Persian Gulf War there is still no definitive case
definition for Gulf War Illness (GWI), a syndromic disorder reported by large number of
servicemembers deployed in support of the war. Currently accepted case definitions define
GWI with different groups of medical conditions including pain, fatigue, cognitive, respiratory,
dermatologic, and gastrointestinal disorders; however, these case definitions have not been
validated or replicated and their reliability has not been determined. Due to the array of
symptoms reported by Gulf War veterans, there is considerable overlap among these current
GWI definitions and existing syndromic disorders, such as chronic fatigue syndrome, irritable
bowel syndrome, and fibromyalgia. The objective of this dissertation is to explore health
outcomes associated with GWI using currently accepted classifications in order to better
understand and define the disorder by examining pre-war medical conditions as predictors of
probable GWI, mortality outcomes of veterans with probable GWI, and female-specific medical
conditions among women with probable GWI. Additionally, we develop and utilize an
alternative GWI case definition conforming to recommendations from a systematic review of
GWI studies.
Methods:
Data come from the Department of Veterans Affairs (VA) 1995 National Health Survey of
Persian Gulf War Era Veterans, a population-based survey of 30,000 deployed and nondeployed Gulf War era veterans (70% response rate). We classified respondents as meeting the
criteria for the two currently accepted definitions of GWI. For Aim One, we examined pre-war
medical conditions as predictors for probable GWI using the two currently accepted
classifications in addition to our new definition. For Aim Two, we matched social security
numbers of survey respondents to the Joint Department of Defense/VA Mortality Data
Repository for years 2000-2014 to determine vital status and cause-specific mortality risk
among those with and without probable GWI. For Aim Three, we matched female survey
respondents to VA electronic medical records for years 2000-2017 and analyzed risk for femalespecific medical conditions among those with and without probable GWI.
Results:
Aim One: All pre-war medical condition predictor group variables (pain, dermatologic,
genitourinary, gastrointestinal, neurological, cardiac, respiratory, and inflammation) included in
the respective logistic regression models were significantly associated with the 3-domain and
CDC/Kansas measures of GWI. Results from this study suggest pre-war factors are associated
with increased risk for meeting criteria for GWI following deployment to the Persian Gulf War.
Aim Two: Deployed veterans meeting criteria for GWI in 1995-1997 were at increased risk for
cause-specific mortality due to malignant neoplasms, circulatory system disorders, and

digestive system disorders, and had greater risk for overall mortality compared to deployed
veterans who did not meet criteria for GWI. However, when compared to non-deployed
veterans with probable GWI, deployed veterans with probable GWI had decreased overall
mortality risk and decreased risk for mortality due to diseases of the circulatory system.
Aim Three: Deployed women meeting criteria for either the CDC or Kansas definition of GWI in
1995 were at increased risk for disorders of the breast and female genital tract compared to
non-deployed women who did not meet GWI criteria. Within the deployed group, women
meeting criteria for GWI had increased risk for disorders of the female genital tract compared
to those not meeting GWI criteria.
Conclusion:
Our findings add to the GWI literature by presenting results for previously unexplored aspects
of the disorder. We were able to identify an association between pre-war medical conditions
and post-war probable GWI, indicating that some veterans may have had a pre-existing
vulnerability for developing GWI-related conditions. Additionally, we demonstrate use of an
alternative case definition for GWI, which was also associated with pre-war predictors. Our
mortality results indicate that deployed veterans meeting criteria for GWI in 1995 had some
increased risk for GWI-related causes of death, plus mortality due to malignant neoplasms.
Finally, we found some evidence of increased risk for female-specific medical conditions among
deployed women with GWI symptoms, though we are unable to determine if the findings are
related to GWI domains, deployment conditions, or pre-war factors. Our findings support the
ongoing need to prioritize GWI research and continued development of a validated and reliable
measure for classification of GWI.
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Chapter 1
Introduction
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Chapter 1: Introduction
1.1 Background
1.1.1 History of Gulf War and Gulf War Illness
Beginning on August 8, 1990, the United States (U.S.) deployed 697,000 troops to Saudi Arabia
in support of Kuwait after an Iraqi invasion led by Saddam Hussein known as Operation Desert
Shield. Iraq refused to withdraw from Kuwait and the conflict developed into a massive U.S.-led
airstrike beginning on January 17, 1991, known as Operation Desert Storm, which progressed to
a ground war in mid-February and ended in a cease-fire on February 28, 1991 [1]. While this
was considered a relatively short conflict in comparison to other U.S.-involved wars, many of
those who deployed in support of the war have been impacted by persistent negative health
outcomes assumed to be linked to deployment or related exposures of war.
Soon after their return from the Gulf War, military servicemembers and veterans began
reporting multiple, varying, and difficult to diagnose clusters of health problems, such a pain,
fatigue, respiratory problems, cognitive issues, and gastrointestinal illnesses. Utilizing samples
of various military and veteran cohorts, researchers conducted epidemiological studies to
investigate these symptoms in an effort to explore clustering of highly prevalent symptoms and
define the disorder, which became known first as Gulf War Syndrome, then chronic multisymptom illness, and finally Gulf War Illness (GWI), the signature disease of the Gulf War era.
However, 29 years after the Gulf War, the fundamental task of defining GWI is still ongoing; no
definitive, validated case definition has ever been developed [2], which has led to a quarter
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century of complications and delays in treatment research and frustrated veterans who are still
suffering.
1.1.2 Definitions of Gulf War Illness
At least 40 studies have been published attempting to describe and group symptoms of GWI or
develop case definitions using Gulf War deployed and non-deployed cohorts from the U.S. and
Europe, military unit-specific subsets of deployed and non-deployed Gulf War veterans or
servicemembers, and Gulf War registries [2] (Appendix 1). The range of symptoms reported and
lack of details about onset, duration, and severity in many studies has made it difficult to use
symptom-based research to develop a case definition for GWI [2]. Five studies attempted to
define a case definition for GWI, which are referred to as the Haley, CDC, Portland, Kansas, and
Kang definitions of GWI.
Haley
In 1995 and 1996, using a small cohort (n=249) of Gulf War deployed servicemembers and
veterans from a Naval Reserve Unit, a group of researchers [3] conducted a survey and
analyzed data using a two-stage factor-analysis approach to determine syndromes. Based on
their analyses, they reported discovery of six syndromes: impaired cognition, confusion-ataxia,
arthro-myo-neuropathy, phobia-apraxia, fever-adenopathy, weakness-incontinence.
Syndromes one through three had strongly clustered symptoms, while syndromes four through
six were weakly clustered, with strong overlap with syndromes two and three. This study was
small and lacked a comparison group. Haley, et al conducted a validity study in 1996 through
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1997 using a group of 335 Active Duty U.S. Army servicemembers living in Texas [4]. Results of
this validation study indicated three syndromes based on factor analysis of symptoms from the
previous study: impaired cognition, confusion-ataxia, and central pain. The Haley, et al studies
present the most statistically robust attempts at defining GWI, though this research is limited
by small sample sizes and lack of generalizability in both publications.
CDC
Fukuda, et al conducted a clinical examination and survey study with a sample of approximately
3,700 U.S. Air Force veterans in 1995 in an attempt to define GWI [5] using two methodologies–
confirmatory factor analysis and symptom-category approach. Ultimately, their case definition
was based on the symptom-category method due to the ease of use in a clinical setting. They
defined GWI as having one or more symptoms for 6 months or more in at least two of the
following categories: fatigue, mood and cognition (feeling depressed, difficulty remembering or
concentrating, moody, anxious, trouble finding words, sleep problems), and musculoskeletal
(joint pain or stiffness, muscle pain). Cases were considered severe if all symptoms reported
were severe. Based on this definition of GWI, which is referred to as the CDC definition, 39% of
their surveyed deployed Gulf War veterans met the criteria for mild-moderate GWI compared
to 14% of the non-deployed veterans met the criteria. This study is limited by its use of a
specific geographical cohort of U.S. Air Force veterans. Additionally, no studies have validated
the case definition developed by this research.
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Portland
VA researchers and collaborators from Portland, Oregon conducted a two-phase case-control
study of Gulf War veterans in the Northwestern area of the U.S. in November 1995 through
January 1998. Phase I involved a survey of deployed Gulf War veterans (n=1,119 respondents)
followed by Phase II, a clinical follow-up study (n=357) [6]. Based on factor analysis performed
using survey data and analysis of the case-control study data, the definition of GWI developed
by this group required at least one symptom occurring for at least one month in the previous
three months in the follow categories: fatigue, cognitive and psychological, and
musculoskeletal. For the fatigue group of symptoms, the following criteria must be met:
unexplained fatigue must be accompanied by at least four additional symptoms: fever/chills,
new headaches, unrefreshing sleep, tender glands, memory problems or difficulty
concentrating, sore throat, painful joints, unexplained muscle weakness, muscle aches, feeling
ill for a day or more after exercising. Results from this study are limited due to small sample
sizes and lack of generalizability to the greater Gulf War deployed cohort.
Kansas
In 1998, a survey of approximately 3,000 Gulf War veterans living in Kansas was conducted to
investigate increased burden of health issues among deployed Gulf War veterans [7]. This study
resulted in what is commonly referred to as the Kansas definition of GWI. Based on correlations
of symptom scores and comparison of symptom groups between deployed and non-deployed
veterans in the study, five groups were identified: fatigue/sleep problems, pain symptoms,
neurologic/cognitive/mood symptoms, gastrointestinal symptoms, and respiratory symptoms.
5

A sixth group, skin symptoms, was added based on one skin related question on the survey.
Exclusionary criteria included serious psychiatric illness and a list of chronic diseases including
heart disease, cancer, diabetes, chronic infectious diseases, problems resulting from postwar
injuries, liver disease, lupus, multiple sclerosis, or stroke. To be classified as a GWI case
according to this definition, the veteran must have reported one moderately severe symptom
or two or more symptoms in a group in at least three of the six symptom categories, with no
exclusion criteria. According to this definition, 34% of deployed veterans and 8% of nondeployed veterans met the criteria for GWI. This study also applied the CDC criteria for GWI to
their respondents and reported 3.26% of deployed and 1% of non-deployed met criteria for
GWI.
Kang
A survey conducted by Kang, et al, at the Department of Veterans Affairs (VA) in 2005 as a 10year follow up to the 1995 National Health Survey of Persian Gulf War Era Veterans (NHS) [8]
defined GWI (referred to as unexplained multi-symptom illness) as “having several different
symptoms together that persist for 6 months or longer and are not adequately explained by
conventional medical or psychiatric diagnoses.” Symptoms included in this definition are
fatigue, headaches, joint and muscle pain, and respiratory problems. The description of the
definition used for this study is vague and specific criteria are not listed, making it difficult to
deem this a new or revised definition of GWI. Regardless, the authors reported that 36% of Gulf
War deployed respondents and 11% of non-deployed responses met criteria for multi-symptom
illness. Recently, errors were discovered in the 2005 survey data, making this publication an
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unreliable source (unpublished; personal communications with VA). The IOM considers this
publication an attempt at a case definition for GWI, though considering the lack of a description
of methodology and no specific criteria for classification, in addition to the survey data errors,
published results from this study may not be reliable.
In 2014 the Institute of Medicine (IOM) published a systematic review of the GWI literature,
which concluded that three symptom domains occur consistently across all published studies
(fatigue, pain, and neurocognitive disorders), and three additional domains occur in all
symptom-based publications (respiratory, gastrointestinal, and dermatologic disorders). Based
on these findings, the IOM determined that no existing case definition fully captured the
findings from the systematic review, and most are additionally missing important components
of case definitions, including details regarding laboratory findings, onset, duration, frequency,
and severity of symptoms. IOM ultimately recommended continued research towards a
definitive case definition for GWI; however, they stated that the CDC [5] and Kansas [7] case
definitions could be used to identify veterans with GWI until an ideal case definition is
developed.
The IOM stated that the CDC definition of GWI identified the three most common domains
occurring in symptomatic Gulf War veterans, however, this is not entirely accurate. While the
CDC definition includes fatigue as a domain, the other two domains representing pain and
neurocognitive disorders are more limited in scope than what was summarized by the IOM as
occurring in all publications. In the CDC definition, pain is represented by “musculoskeletal
symptoms,” specifically referring to joint and muscle pain [5]. Neurocognitive disorders are
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represented by a “mood and cognition” domain, which includes depressive symptoms and
anxiety, two commonly occurring mental health disorders that often co-occur with physical
health issues but excludes additional and potentially important neurocognitive disorders such
as chronic headaches and migraines. The IOM rationalized the use of the Kansas definition for
GWI due to the inclusion of a version of all six of the domains found in their systematic review
of the literature. While their pain, neurocognition, and fatigue domains seem fitting, the
inclusion of the three additional domains (gastrointestinal, respiratory, and skin symptoms) that
were only found in some GWI publications may mean that this definition is identifying a large
number of false positives. Additionally, it is important to note that the Kansas definition criteria
includes exclusionary criteria for severe psychiatric disorders and several chronic diseases
(heart disease, cancer, diabetes, chronic infectious diseases, problems resulting from postwar
injuries, liver disease, lupus, multiple sclerosis, or stroke) [7].
Using the CDC and Kansas definitions of GWI could result in misclassification of cases due to
decreased sensitivity and specificity; although no studies have demonstrated validity of either
of these definitions. Additionally, both of these definitions were conducted on relatively small
samples in very specific, non-generalizable populations (approximately 2,000 Kansas Gulf War
veterans included in the Kansas study and approximately 3,700 U.S. Air Force veterans from 4
units who served in the Gulf War in the CDC study) [5, 7]. Considering the many subsequent
studies that have proceeded with research on GWI using cases defined by the CDC and/or
Kansas definitions, the IOM may have done the Gulf War research community and veterans a
disservice with this endorsement.
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Support for a definitive disorder unique from other known syndromes responsible for the
increase in symptom reporting among Gulf War veterans was not universal among those
conducting research in this area. Some researchers concluded that their studies did not support
of evidence of a unique GWI [9-11]. A review study by Ismail and Lewis [11] stated that there is
no evidence for a unique GWI and that the symptoms experienced by Gulf War veterans are
similar to medically unexplained syndromes experienced among civilians.
1.1.3 Epidemiology
According to various studies, an estimated 25-50% of veterans who served during the 19901991 Gulf War report symptoms consistent with various definitions of (GWI) [12] [7, 13]. A
primary reason for the broad range of GWI prevalence estimates is lack of a universally
accepted and validated case definition. Without knowing how to define a case, it is nearly
impossible to understand the magnitude of the problem from an epidemiological standpoint.
One recent paper looking at the demographic characteristics reported that GWI is prevalent
among women, Hispanics, African Americans, and veterans who served in the Army, Reserves,
and National Guard [12]. One study reported increased symptom reporting among a cohort of
Gulf War veterans 20 years after the war, though the increase in symptoms was similar in both
deployed and non-deployed groups [14]. To our knowledge, no researchers have investigated
mortality among veterans who met the criteria for GWI.
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1.1.4 Other symptom-based disorders
There are several other syndrome-based disorders for which case definitions have been
developed, such a chronic fatigue syndrome (CFS), irritable bowel syndrome (IBS), and
fibromyalgia, which occur in the general population. Due to the large number of and varied
symptoms involved in GWI, currently defined symptom-based disorders do not completely
explain the common clusters of symptoms seen in this group of veterans [2]. Previous research
studies have demonstrated overlap between GWI and some of these disorders [11], making it
likely that some proportion of the general population experiences symptom patterns of GWI,
though to our knowledge this has not been investigated. For example, it is highly plausible that
a proportion of the general U.S. civilian population, in the same age range as Gulf War veterans,
experience symptoms consistent with the CDC definition of GWI, meeting criteria by
experiencing conditions in two of the three domains of fatigue, mood and cognition, and
musculoskeletal conditions [5]. Studies have demonstrated that non-deployed veterans of the
Gulf War era also experience symptoms consistent with the symptoms included in definitions of
GWI [12].
Chronic fatigue syndrome, also known as myalgic encephalomyelitis, is a difficult to diagnosis
and treat syndromic disorder comprised of symptoms that overlap considerably with GWI
symptoms, such as fatigue, muscle pain, headaches, cognitive dysfunction, and gastrointestinal
issues [15]. Similar to GWI, it took over 30 years to develop an accepted case definition for CFS
[16]. Women are more than twice as likely as men to experience CFS, and the disease often has
a substantial negative impact on quality of life [17]. The currently accepted case definition for
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CFS requires new onset fatigue, post-exertional malaise, and unrefreshing sleep plus either
cognitive impairment or orthostatic intolerance [16]. Research has shown that many patients
with CFS also meet criteria for other syndromic disorders including IBS and fibromyalgia [16].
Fibromyalgia is also described as a difficult to diagnose disorder characterized by widespread
and often migratory pain, frequently accompanied by fatigue, sleep problems, memory issues,
and mood disturbances [18]. These secondary symptoms often subside with pain relief.
Fibromyalgia affects 2% to 8% of the general population and women are more likely to be
affected than men [18]. Again, there is commonality between some definitions of GWI and the
symptoms included in fibromyalgia.
Irritable bowel syndrome (IBS) is another syndromic disorder characterized by symptom
clusters such as constipation, abdominal cramping, and bloating, which are often dynamic and
associated with specific food intake [19]. IBS is estimated to occur in 7% to 21% of the general
population [19], causes decreased quality of life, and co-occurs often with other syndromic
disorders such as CFS and fibromyalgia [20]. The ROME III criteria is currently used to diagnose
IBS, requiring recurrent abdominal pain or discomfort for at least three days per month for at
least three months, with exclusion of organic disease [19]. Given the inclusion of the
gastrointestinal domain for the Kansas definition for GWI, it seems plausible that some patients
meeting the criteria for GWI would also meet criteria for IBS.
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1.1.5 Assumptions of GWI
There are several assumptions inherent in our current understanding of GWI that have yet to
be elucidated. First, it is assumed that GWI is a unique illness due to its proposed domain
construct, meaning that it is meaningfully different from other syndromic disorders and related
combination of domains. There is little evidence to support this statement. In fact, it is likely
that the domains shown to be highly prevalent in deployed Gulf War veterans often occur
together in the general, civilian population as well. However, to our knowledge no studies have
been conducted to apply either of the accepted case definitions to a cohort of the general
population to test this hypothesis. No studies have conclusively demonstrated that GWI is a
uniquely occurring set of symptoms.
Secondly, it is assumed that GWI is an illness that is meaningfully distinct from other syndromebased disorders that have occurred in other military cohorts. One argument for this distinction
has been the prevalence of symptoms among those deployed in support of the Gulf War. The
prevalence of symptoms has been shown to be greater in Gulf War deployed veterans
compared to non-deployed veterans who served during the same time period [2]. In order to
demonstrate that this is a unique disorder to those veterans deployed to the Gulf War, we
would need evidence that GWI rarely occurs in non-deployed cohorts and that this is different
from health outcomes in other military cohorts. Studies have shown that non-deployed
veterans who served during the Gulf War era do experience the combinations of symptoms
used to identify GWI in ample numbers [12]. The various symptoms reported in the GWI
literature do not differ greatly from disorders prevalent in previous military conflicts [21, 22].

12

Additionally, veterans returning from the recent conflicts of Operation Iraqi
Freedom/Operation Enduring Freedom have met the criteria for GWI [23, 24].
These leads to the next assumption of GWI, which is that GWI was caused by some unknown
exposure or exposures during the Gulf War. Studies attempting to address this hypothesis have
not demonstrated correlations between GWI and various exposures including vaccinations, oil
well fire smoke, sarin gas, and depleted uranium [11, 25].
There is an assumption that GWI is independent of underlying vulnerabilities that may interact
with subsequent exposures or otherwise increase risk for GWI following deployment. The CDC
definition for GWI does not include any exclusion criteria, while the Kansas definition does
exclude based on psychiatric and chronic disease history [5, 7]. If GWI is an independently
occurring disorder that is not related to an individual’s underlying health status, then it seems
counterintuitive to apply exclusion criteria to these case definitions. Use of such a definition
could erroneously exclude individuals from research studies and treatment regimens.
Finally, there is an assumption that the latency period between exposure and symptom onset is
boundless; veterans are still eligible for meeting GWI criteria even 30 years after the war, when
symptom causation is increasingly complicated due to the aging population.
1.2 Purpose Statement
The overarching purpose of this dissertation is to explore health outcomes associated with GWI
among Gulf War veterans in order to aid in our understanding of the disorder. Our null
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hypothesis is that there is no evidence that GWI is a disorder unique to veterans of the 19901991 Gulf War.
Nearly 30 years after the war there is still no clear understanding regarding the causes of GWI
or the long-term outcomes among those who have symptoms consistent with the disorder [2].
While numerous studies have researched GWI as a function of military service, significant gaps
exist in our understanding of baseline risk, longer-term outcomes or differences across
demographic groups. Results from this dissertation will address important questions related to
baseline risk for diseases and other disorders associated with GWI. This research provides a
unique opportunity to explore health outcomes and pre-service characteristics among veterans
with symptoms consistent with GWI soon after the end of the war, using data from a
population-based survey, mortality records, and electronic medical records.
To date, there has not been a single analysis that has assessed the possibility that GWI may not
be completely a function of exposures during military service. To our knowledge, only one
previous study of veterans with GWI has considered pre-enlistment factors as predictors of GWI
[26]. This work has important consequences for policies related to federal compensation for
GWI and potential exposures or other characteristics related to this disorder. Similarly, there
has been no research to date that has investigated differences in either all-cause or causespecific mortality potentially associated with GWI. Differences in patterns of mortality
associated with a positive screen for GWI have not been explored. Drawing on a unique data
set collected shortly after the Gulf War, the research included in this project has the potential
to identify differences in patterns of mortality that may shed light on potential exposures or
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previously unrecognized burden of illness. Finally, despite evidence of differential impact of
GWI on women, there has been little research focused on gender-specific diseases or disorders
related to GWI. This dissertation will directly contribute to the existing literature by carefully
considering outcomes unique to a proportionately smaller but clinically important segment of
the veteran population.
Data sources
Data used to address our objectives come from a population-based retrospective case-control
study and VA mortality and electronic medical records. Survey data come from the 1995-1997
National Health Survey of Persian Gulf War Era Veterans (NHS), the largest population-based
cohort study of Gulf War and Gulf War Era veterans conducted to date. A stratified random
sample of 15,000 deployed and 15,000 non-deployed veterans was drawn from DoD records of
all 693,826 troops deployed between September 1990 and May 1991 and 800,680 nondeployed troops, representing approximately half of those who were in the military during the
same time period but did not deploy. Random sampling was based on gender and unit
component (active duty, reserve, National Guard); women and reserve/National Guard were
oversampled. The sample of 30,000 was sent a 16-page self-administered, structured health
questionnaire, followed up with three reminders and a phone call for remaining nonresponders at 6 months [27]. The NHS questionnaire included questions on demographic and
military characteristics, somatic and psychological symptoms, functional limitations, chronic
conditions, self-reported health status, medical care utilization (such as hospitalizations and
physician contacts), smoking, and substance use. Many of the survey questions came from the
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National Health Interview Survey to allow for comparison to the general U.S. population.
Relevant environmental risk factors were also evaluated including immunization history,
pyridostigmine bromide (PB) pills, smoke from oil well fires, diesel, and other chemical
exposures. Respondents included 11,441 Gulf War veterans (75%) and 9,476 Gulf War era (nondeployed) veterans (64%) resulting in an overall response rate of 70%. For each of our three
aims we used veteran respondents to the 1995 NHS who met the criteria for either the CDC or
Kansas definitions of GWI [12].
The data on female-specific health care utilization come from electronic medical records in the
Veterans Health Administration Corporate Data Warehouse (CDW), which houses records for all
veterans who have received healthcare at a VA facility. Mortality data for this study come from
the Joint Department of Defense (DoD)– Department of Veterans Affairs Mortality Data
Repository (all-cause) (MDR), a database containing cause-specific mortality information for all
veterans. The MDR is a combination of multiple federal database including the National Death
Index, DoD specific databases, and Veterans Health Administration files. While developed with
the intent to provide a comprehensive database for military and veteran suicide research in
order to better understand and prevent suicide, the MDR includes information on all deaths
including specific causes of death using ICD-9 and ICD-10 codes [28].
Data for all aims were analyzed using SAS Enterprise Grid software (version 5.1, SAS Institute
Inc.). This study has been reviewed and approved by the Institutional Review Board at the
Syracuse VA Medical Center.
1.3 Specific Aims
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Specific Aim 1: Identify pre-war health predictors associated with meeting criteria for Gulf
War Illness. We hypothesize that pre-war medical symptoms do not predict meeting criteria for
GWI after the war.
To address this aim, we conducted a retrospective case-control study using data from the 1995
National Health Survey of Persian Gulf War Era Veterans (NHS). We applied modified CDC and
Kansas criteria for GWI to deployed and non-deployed respondent data and identified those
who did or did not meet the criteria for either definition. Additionally, we created a new
definition of probable GWI using the recommendations of the IOM [2]. Using these two
definitions of GWI, we investigated pre-war medical conditions and symptoms as risk factors for
predicting probable GWI. We calculated prevalence estimates of pre-war medical conditions
and symptoms stratified by probable GWI status. We performed a series of multivariable
logistic regression analyses evaluating the associations between pre-war medical conditions
and symptoms to probable GWI.
Specific Aim 2: Identify differences in all-cause and cause-specific mortality among veterans
who do and do not meet criteria for GWI. We hypothesize that deployed veterans who meet
criteria for GWI will have significantly greater risk for all-cause and cause-specific mortality.
As in the first aim, respondent identifiers and probable GWI status come from the NHS. Veteran
identifiers were matched to mortality data from the MDR. We calculated crude all-cause and
cause-specific mortality rates stratified by probable GWI classification. Next, we calculate ageand gender-adjusted all-cause and cause-specific mortality hazard ratios using Cox proportional
hazard models comparing veterans who did and did not report GWI symptomology.
17

Specific Aim 3: Identify differences in risk for reproductive disorders among women who do
and do not meet criteria for GWI. We hypothesize that women who were deployed to the
Persian Gulf War who met criteria for GWI will have higher incidence for reproductive disorders.
Data for this aim come from respondents to the NHS limited to those who self-reported as
women on the survey. This cohort of women veterans was matched to the VA medical record
database to identify all International Classification of Disease (ICD) codes in inpatient,
outpatient, emergency department, and fee-for-service medical records related to femalespecific health conditions (e.g., endometriosis, spontaneous abortions, etc). We calculated
incidence estimates of female-specific medical conditions among women who did and did not
meet the criteria for GWI according to the CDC and Kansas definitions. Next, we calculated
indirectly age-adjusted standardized incident rate ratios and adjusted hazard ratios using Cox
proportional hazard models adjusting for race/ethnicity and age group.
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Predicting Gulf War Illness Using Pre-War Medical Conditions
Abstract
Introduction: Though a validated and universally accepted case definition still does not exist,
presumptive Gulf War Illness (GWI) remains a significant health concern for many Gulf War
veterans. Pre-war health conditions of Gulf War veterans are mostly unexplored and could aid
in developing a more accurate case definition of GWI. The objective of this study was to
investigate pre-war predictors of Gulf War Illness (GWI) using survey data from a populationbased sample of Gulf War veterans.
Methods: Using two definitions of GWI (CDC/Kansas combined and a newly developed 3domain definition), we calculated a series of multivariable logistic regression models to identify
correlates of pre-war medical characteristics and GWI. Predictors were grouped in the following
categories: pain, dermatologic, genitourinary, gastrointestinal, neurological, cardiac,
respiratory, and inflammation.
Results: All predictor group variables included in the respective models were significantly
associated with the 3-domain and CDC/Kansas measures of GWI.
Conclusion: In this study, meeting criteria for GWI in 1995, using either the CDC/Kansas version
or 3-domain definition was predicted by all pre-war medical conditions considered in this
analysis. Results from this study suggest pre-war factors are associated with increased risk for
meeting criteria for GWI. Subsequent studies should consider the reliability of measures used to
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classify GWI and the possibility that pre-war factors may be associated with increased
vulnerability for GWI or symptoms of similarly presenting disorders.
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Introduction
An estimated 25-50% of veterans who served in the 1990-1991 Persian Gulf War reported
experiencing a syndrome of medical conditions after return from deployment, commonly
referred to as Gulf War Illness (GWI) [1-3]. GWI is characterized by clusters of medical
symptoms including fatigue, pain, dermatological and cognitive symptoms, and disorders of the
respiratory, neurological, and gastrointestinal systems, which have been included in various
efforts to classify GWI since the mid-1990’s [4]. While veterans with GWI continue to report
symptoms consistent with this syndrome 30 years post-war, no definitive case definition exists,
creating a challenge for categorization of disease status and assessment of treatment options
[4].

Historical studies and reports have shown similar clusters of symptoms occurring among
veterans from all United States (U.S.) military conflicts since the Civil War, as well as military
conflicts in other countries [5-8]. The high prevalence of symptoms consistent with syndromic
illness among deployed veterans of the 1990-1991 Gulf War makes GWI a disorder unique to
this population of veterans [6, 9, 10].

To understand the increased symptom reporting and related conditions among Gulf War
veterans, it is important to acknowledge the baseline risk of related medical symptoms in the
general U.S. population. An epidemiologic study published in 1993 reported the most common
medical conditions in the United States were joint pain (37% prevalence), back pain (32%
prevalence), headaches (24.9% prevalence), and fatigue (24% prevalence); all symptoms
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included in currently-accepted classifications of GWI [11]. Importantly, one of the earliest and
most widely used measures of GWI [2] reported an excess burden of a specific cluster of
conditions, theoretically associated with deployment to the 1990-1991 Persian Gulf War,
ranging from 25-30%.

Shortly after the 1990-1991 Gulf War, researchers attempted to classify distinct groupings of
symptoms and achieve consensus on a common definition of GWI, a difficult task given the
myriad of conditions being reported, as well as differences in sampling and study design [12,
13]. In 2014, the Institute of Medicine (IOM) published a systematic review of existing GWI case
definitions and ultimately determined no published case definition accurately captures the
groups of symptoms and diagnoses consistently reported in studies of this population [4]. In
addition to recommending continued efforts towards developing a case definition for GWI, IOM
endorsed the use of two existing definitions that they felt most closely captured GWI symptoms
in the published literature: the definition developed by the Centers for Disease Control and
Prevention (CDC) [14] and the definition developed by Steele, referred to commonly as the
Kansas definition [2]. Neither of these case definitions have been validated or tested for
reliability [4].

A recent publication classified veteran respondents as meeting criteria for GWI according to the
CDC and Kansas definitions using historical data from the Department of Veterans Affairs’
population-based National Health Survey of Persian Gulf War Era Veterans (NHS) [1]. This study
estimated 40-50% of deployed veterans met the criteria for GWI according to these definitions.
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Additionally, this study estimated a relatively high prevalence (17%) of probable GWI cases in
non-deployed veterans using these same case definitions, a finding consistent with prior
research studies [3]. In the absence of an empirically-supported explanation, the paradoxically
high prevalence of non-deployed veterans meeting criteria for a condition thought to be related
to deployment to a particular region and conflict raises questions about both the reliability and
validity of existing assessments and resulting estimates of disease burden generated by their
use. Several studies have demonstrated overlap of symptoms of GWI with symptoms included
in other established syndromic disorders, including chronic fatigue syndrome, irritable bowel
syndrome, and fibromyalgia, further complicating efforts to identify characteristics uniquely
associated with GWI [2, 15-18].

Multiple studies have investigated the relationship between prevalence of GWI symptoms and
wartime exposures of the 1990-1991 Persian Gulf War, including oil well fire smoke, nerve
agents at a munitions depot (Khamisiyah), pyridostigmine bromide (PB, an anti-nerve agent),
vaccinations, and depleted uranium (used for tank armor and bullets), however results from
these studies are inconclusive. A 1997 survey of Gulf War veterans found that those who
reported exposures to PB, oil well fire smoke, tent heaters during deployment, anthrax
vaccination, and chemical odors were more likely to meet criteria for the CDC definition of GWI
compared to those without those exposures [19]. However, a case-control study of Kansas-area
veterans found no increased risk for meeting the criteria for GWI among veterans who reported
exposure to oil well fire smoke [20]. This same study reported increased risk for meeting GWI
criteria among veterans who reported wearing uniforms treated with pesticides compared to
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those without, but no increased risk among veterans reporting other pesticide exposures [20].
They also found increased risk for meeting criteria for GWI among veterans who reported
taking PB pills compared to those who did not [20]. A review by the IOM reported inadequate
evidence to establish an association between multiple vaccinations and chronic health
outcomes [21]. Using data from the NHS, researchers reported few differences in health
outcomes between veterans reporting exposure to potential sarin and cyclosarin nerve agents
(Khamisiyah), though GWI criteria was not assessed in this study [22]. A cross-sectional study
found increased risk for separate GWI symptoms among veterans with self-reported exposure
to pesticides during Gulf War deployment, though this study also did not investigate those
meeting all criteria for GWI [23]. Finally, a cross-sectional study of Air Force veterans reported
increased risk for CDC’s definition of GWI among those self-reporting exposure to PB and
pesticides [24].

The lack of in-theater measurement of these exposures has made classification of these
exposures difficult, relying instead on veteran self-report and environmental modeling of
exposure to airborne chemicals and smoke [21]. Additionally, research on environmental
exposures is complicated by multiple and varied exposures experienced by those deployed to
areas of conflict. Many studies reporting the relationships between wartime exposures and
GWI lack generalizability due to small sample sizes and limited or specific groups of veterans
sampled. Various definitions of GWI have been used in these studies, making comparisons
across studies problematic. Studies of veterans who deployed to Iraq and Afghanistan in
support of Operation Iraqi Freedom (OIF) and/or Operation Enduring Freedom (OEF) report
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high prevalence of veterans meeting the criteria for GWI [25, 26], an indication that GWI may
not have been caused by a unique exposure or experience during the 1990-1991 Gulf War.

To date, studies investigating pre-war predictors of GWI are limited. A follow-up study using a
subset of respondents to the NHS reported an association between pre-war anxiety and
depression and chronic multi-symptom illness (a term previously used to refer to GWI) in both
deployed and non-deployed veterans of the Gulf War era [27]. This is in an indication that, to
some extent, those meeting criteria for GWI had some pre-war health differences compared to
those without probable GWI, and further studies should explore additional pre-war health
conditions. Cross-sectional data from the 1995-1997 NHS study provides a unique opportunity
to utilize responses to pre-war medical condition questions collected approximately five years
post-war as predictors of early onset GWI [28].

Investigating the associations between pre-war medical conditions and symptoms consistent
with definitions of GWI may help researchers understand if certain veterans were likely to
develop GWI-like illness regardless of deployment status and may help researchers refine
currently accepted definitions of GWI. The objective of this study was to determine which, if
any, pre-war medical conditions predict meeting criteria for GWI using survey data from a
representative sample of Gulf War veterans. Additionally, this study also compares the
prevalence and risk of pre-war medical condition predictors among a newly developed, 3domain definition of GWI derived from a review of criteria reported by existing studies
(CDC/Kansas) [2, 4, 14].
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Methods
Measures:
Data for this study came from the 1995-1997 National Health Survey of Persian Gulf War Era
Veterans (NHS) [28]. This population-based study collected health and military exposure data
from a stratified random sample of 15,000 deployed Gulf War veterans and 15,000 nondeployed veterans using a 16-page mailed survey with telephone follow-up for non-responders.
Deployed veterans were sampled from all 693,826 Gulf War veterans deployed between August
1, 1990 and March 1, 1991, as determined by the Department of Defense’s Defense Manpower
Data Center. Fifteen thousand non-deployed veterans were sampled from 800,690 veterans,
representing half of those who served in the military during the same time period but did not
deploy to the 1990-1991 Persian Gulf War. The samples were stratified by gender, unit
component (active duty, National Guard, Reserves), and branch of service (Air Force, Army,
Navy, Marine Corps). A detailed description of study design and methods is described in a
previous publication [29]. Analyses included in this study were limited to deployed veterans.

Gulf War Illness definitions:
We used two definitions of GWI as outcome measures for these analyses, based on results from
an existing 2014 IOM systematic review of all GWI scientific research publications. The IOM
concluded after reviewing the existing published GWI classification methods that no complete
or ideal case definition currently exists in the published literature. The definition developed by
the Centers for Disease Control and Prevention (CDC) [14] and the definition developed by
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Steele, referred to commonly as the Kansas [2] definition, were recommended by the IOM as
the best options for classifying GWI. The first definition of GWI used in our analyses is a
combination of the CDC and Kansas definitions of GWI. Details on how the Kansas and CDC
definitions were modified using the NHS survey data are available in a previous publication [1].
Briefly, to meet criteria for the Kansas definition of GWI the veteran must have reported a
condition occurring for the first time during or after the Gulf War in three of the following six
domains: fatigue, pain, neurological/mood/cognition, gastrointestinal, respiratory, and skin.
Consistent with previous use, respondents were excluded for self-reported history of cancer,
diabetes, heart disease, liver disease, or stroke, or overnight hospital stays for mental health
disorders. To meet criteria for the CDC definition, the veteran must have reported conditions in
two of three domains: fatigue, mood or cognition, and musculoskeletal. There were no
exclusion criteria for the CDC definition. For these analyses, the Kansas and CDC definitions of
GWI were combined into a variable referred to as “CDC/Kansas GWI.” Survey respondents
meeting either the CDC or Kansas definition were considered GWI cases.

In the IOM’s 2014 systematic review, they identified three groups of symptoms that appear
routinely in all existing attempts at classifying GWI (24 studies on symptoms including five
studies that attempt to classify GWI): fatigue, pain/musculoskeletal, and neurocognitive
dysfunction [4]. While the CDC and Kansas definitions are the most frequently used
classification methods, neither of these definitions have been validated and both were
developed using limited samples. Due to the extensive information on medical conditions and
symptoms available from the NHS survey, we developed a new definition of GWI conforming to

31

the three domains identified by the IOM as being present in all existing efforts [4]. Deployed
NHS respondents were classified as a “3-domain GWI” case if they had at least one during- or
post-war symptom in each of the three domains: fatigue, pain, and neurocognitive dysfunction.
In contrast to the CDC/Kansas GWI definition, the 3-domain GWI definition used symptoms to
define cases rather than diagnosable medical conditions. Veterans reporting overnight hospital
stays for psychoses were excluded (ICD-9 295-299). A sensitivity analysis was conducted to
compare the 3-domain GWI definition to the CDC/Kansas GWI (Supplement 1). Supplement 2
displays the frequency counts of the medical symptoms and conditions for each domain,
stratified by GWI definition.

Predictors:
Two survey questions on the NHS included lists of medical conditions and diseases with
response options to indicate if the condition first occurred before, during, or after the 19901991 Persian Gulf War. Conditions that were included in either the CDC/Kansas GWI or the 3domain GWI definitions were excluded as potential predictors for that definition, resulting in
two sets of predictors, one specific to each definition. To be considered a predictor, the
respondent must have indicated initial symptoms or conditions with a date of onset before the
war. Survey respondents with a missing response for any predictor variable were excluded from
the final analytic database. A variable indicating the number of predictors was created for
inclusion in regression models with levels 0, 1, 2, 3, 4 and 5 or greater.

Predictor groups:
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Predictor variables were collapsed into grouped categories based on body systems. An
exploratory factor analysis was conducted, though there was no evidence of factor groupings.
For the CDC/Kansas definition the predictor groups were pain, genitourinary, neurological, and
inflammation. The predictor groups used for the 3-domain definition of GWI include pain,
dermatologic, genitourinary, gastrointestinal, neurological, cardiac, respiratory, and
inflammation.

Demographic and other health status variables:
Demographic variables included age group in 1991 (17-22, 23-32, 33+), gender (men vs.
women), and race/ethnicity (white, non-Hispanic vs. other). Smoking status questions were
combined into one variable with levels “never smoked,” “former smoker,” “current smoker,”
representing smoking status at the time of survey completion. Questions about alcohol
consumption were combined into a single variable with levels “never drank,” “former drinker,
“current drinker.”

Statistical analyses:
Survey weights were applied to account for stratified sampling design and oversampling of
women and National Guard/reservists [28]. Frequency counts, weighted percentages, and Wald
chi-square estimates of demographic variables, smoking history, and drinking history were
stratified by GWI definition. We calculated gender- and GWI definition-stratified frequency
counts, weighted percentages, and Wald chi-square values for conditions included in the
CDC/Kansas GWI and 3-domain GWI definition domains and predictor variables.
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A series of weighted, multivariable logistic regression models were created to calculate risk of
both definitions of GWI based on pre-war medical conditions. Model one includes only the
demographic and health history variables for each GWI definition. Model two includes all
demographic and health history variables plus the count of predictor variable for each GWI
definition. Model three includes all definition-specific potential predictor groups, plus
demographics and health history variables. For model four, 12 separate regression models were
created for each individual predictor variable, controlling for demographics, health history
variables, and count of predictors. Model five is the full multivariable model with all statistically
significant predictor groups, demographics, health history variables, and count of predictors.

Two additional sets of models were developed to investigate interactions. Model six includes
separate multivariate logistic regression models, one for each predictor group, with the
inclusion of a multiplicative interaction term for each predictor group and gender, plus
demographic, health history, and count of predictor covariates. Model seven includes additive
interaction models, one for each predictor group plus every other predictor group, for each
GWI definition.

For all multivariable logistic regression models, predictor variables were entered as ordinal level
variables with the reference group set as “no condition,” producing weighted, adjusted odds
ratios for two time periods (conditions reported before or during the war compared to after the
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war). Data were analyzed using SAS Enterprise Grid software (version 5.1, SAS Institute, Inc.).
Alpha was set at 0.05 for all analyses.

Results
The total analytic subsample included 6,178 deployed veterans. Frequency counts, weighted
percentages and Wald chi-squares and p-values of demographic and health risk factors for the
3-domain and CDC/Kansas GWI definitions are presented in Table 1. Overall, 29.37% of
deployed group met criteria for new GWI compared to 51.68% who met criteria for CDC/Kansas
definition of GWI. Women represented approximately 7% of both definitions of GWI. The
distribution of demographic characteristics and health history variables were similar for both
definitions. Table 2 displays the overlap in positive (29.16%) and negative (48.11%) cases for
both the 3-domain and CDC/Kansas definitions of GWI. Table 3 presents the prevalence of
individual and grouped predictor variables by GWI definition. The prevalence of predictors was
similar across shared predictor groups. For respondents meeting criteria for the 3-domain
definition of GWI, approximately 30% had a pre-war respiratory condition.

Findings from multivariable logistic regression models for predictor groups stratified by GWI
definitions are shown in Table 4. In Model One, which only includes demographics and smoking
and drinking history, women were more likely than men to meet the criteria for both
definitions of GWI (adjusted odds ratio [aOR]= 1.44, 95% confidence interval [CI] = 1.20, 1.74
for 3-domain GWI; aOR = 1.75, 95% CI = 1.46, 2.11 for CDC/Kansas GWI). Veterans reporting
non-white race/ethnicity were more likely to meet the criteria for both definitions of GWI
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compared to those identifying as white (aOR = 1.31, 95% CI = 1.10, 1.56 for 3-domain GWI; aOR
= 1.37, 95% CI = 1.16, 1.62 for CDC/Kansas GWI). Current smokers were significantly more likely
to meet GWI criteria for both definitions compared to those who reported never smoking (aOR
= 1.67, 95% CI = 1.42, 1.97 for 3-domain GWI; aOR = 1.81, 95% CI = 1.56, 2.11 for CDC/Kansas
GWI). For the CDC/Kansas definition of GWI, those in the youngest age group were at greater
risk for meeting GWI criteria compared to those in the oldest age group (aOR = 0.74, 95% CI =
0.61, 0.88) and former drinkers were at greater risk compared to those who reported never
drinking (aOR = 1.62, 95% CI = 1.15, 2.29).

Model Two includes the count of predictor variables in addition to the covariates included in
Model One. For 3-domain GWI, each increase in the count of predictor variables was associated
with an 11% increased risk of meeting GWI criteria (aOR = 1.11, 95% CI = 1.06, 1.16). For the
CDC/Kansas GWI definition, increasing levels of predictors increased risk by 63% for meeting
GWI criteria (aOR = 1.63, 95% CI = 1.42, 1.87).

Model Three includes a set of 12 multivariable models with predictor groups in addition to
demographic and health history covariates. All predictor groups were associated with a 2- to 3fold increased risk for 3-domain GWI compared to those without the pre-war conditions.
Similarly, with CDC/Kansas GWI each predictor group was associated with 2- to 3.3-fold
increased risk for meeting CDC/Kansas requirements for GWI.

36

Model Four is another set of 12 models (labeled a – h), which included all covariates listed in
Model Three with the addition a count of predictor variables. All predictor group variables
remained statistically significant even when controlling for the count of predictors, for both
GWI definitions. The count of predictors was marginally statistically significant for the 3-domain
GWI outcome for all predictor groups variables except cardiovascular disease. For the
CDC/Kansas GWI outcome, the count of predictor variables was associated with an increased
risk of 38-48% per additional condition.

Model Five is the full model with all statistically significant predictors identified in Models 1- 4,
demographics, health history variables, and a count of individual predictors. For both GWI
definitions, all predictor group variables were statistically significant. The count of predictors
was not statistically significant for either the 3-domain (aOR = 1.01, 95% CI = 0.95, 1.08) or
CDC/Kansas (aOR = 1.05, 95% CI = 0.90, 1.22) definition of GWI.

Supplement 3 shows the results of the multiplicative (Model Six) and additive (Model Seven)
interaction models. The only multiplicative interaction that was statistically significant was the
interaction of gender by inflammation for the CDC/Kansas GWI outcome (aOR = 1.36, 95% CI =
1.05, 1.75). All additive interactions were statistically significant.

Conclusion
Results from these analyses demonstrate that GWI can be explained by pre-war medical
conditions and symptoms. Deployed Gulf War veterans reporting pre-war medical conditions
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considered in this analysis were significantly more likely to meet criteria for GWI according to
the CDC or Kansas definitions, as well as a more restrictive 3-domain definition, compared to
those who did not have pre-war conditions. These findings remained statistically significant
when controlling for multiple categories of pre-war medical conditions and an overall count of
the number of pre-war conditions, demographic characteristics and health risk behaviors.

To our knowledge this is only the second study to investigate pre-war predictors of probable
GWI among veterans of the 1990-1991 Gulf War. The previous study found that pre-war
depression and anxiety predicted GWI [27]. These findings indicate a difference in pre-war
mental health status among those who later met criteria for GWI. Our findings add to the scant
research on baseline, pre-war differences among those who develop GWI symptoms; there is
now evidence to show both mental health and medical conditions are associated with
increased risk for GWI. Development of a refined definition for GWI should consider the
possible influence of pre-war mental health and medical conditions.

As part of these analyses we had the unique opportunity to construct a case definition limited
to the three domains recommended by the IOM (fatigue, pain/musculoskeletal, and
neurocognitive dysfunction) using 1995-1997 survey data from the NHS, a population-based
survey of deployed and non-deployed Gulf War veterans [4]. Development of a 3-domain
version of defining GWI is supported by the IOM’s review of all published studies attempting to
define GWI. We were able to capitalize on existing survey data from early after the war to
develop a version aligned with the IOM’s suggested ideal case definition. While the CDC
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definition of GWI also uses three domains, one marked difference is the lack of mood disorders
in our neurocognitive domain. Using this new definition, 29% of deployed Gulf War veterans
met the criteria for GWI, compared to nearly 52% of deployed veterans meeting the criteria for
the CDC or Kansas versions of GWI. While our analyses were limited to deployed and therefore
not presented in the results, in the non-deployed respondent group, only 8% met the criteria
for 3-domain GWI while nearly 24% met the criteria for CDC/Kansas GWI. We hypothesize that
the 3-domain version represents a definition of GWI with greater specificity compared to either
the CDC or Kansas definitions. Results from this study suggest that the 3-domain definition of
GWI may more accurately capture true cases compared to the CDC/Kansas definition; although
a gold standard remains elusive.

There are some weaknesses to this study including potential differential recall bias on selfreported survey data among deployed and non-deployed veterans as well as those who were
feeling ill compared to those not experiencing post-war medical symptoms. Our application of
the CDC and Kansas definitions of GWI, the new 3-domain GWI definition, and the pre-war
medical condition predictors were limited by the questions included on the survey. Large
numbers of missing values were a limitation when selecting predictor variables. Additionally,
we were unable to determine if survey respondents who did not meet criteria for CDC/Kansas
GWI or 3-domain GWI at the time the survey was administered later met those criteria. This
study has several strengths including the population-based cohort, large overall response rate
of 70%, and timeliness of survey administration [28]. To our knowledge, no other populationbased surveys exist for the Gulf War veteran population.
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These findings suggest that some veterans deployed in support of the Gulf War may have had
an underlying vulnerability for GWI prior to deployment associated with existing medical
conditions or that some undetermined portion of veterans currently classified as meeting
criteria for GWI may be more accurately classified with another syndrome-based disorder. The
pursuit of a case definition for GWI continues and this study indicates the importance of
inclusion of pre-war medical conditions when developing an updated case definition. The use of
the 3-domain version of a GWI definition demonstrates a possible improvement in specificity
and should be investigated further.
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Mortality among Veterans with Early-Onset Gulf War Illness: a 25-Year Follow-Up
Abstract
Introduction: Several previous studies have described mortality outcomes among Gulf War
veterans, however, no known studies to date have investigated patterns of mortality among
veterans meeting criteria for Gulf War Illness. The purpose of this study is to compare all-cause
and cause-specific mortality rates of Persian Gulf War veterans who did and did not meet
criteria for GWI.
Methods: This study used veteran respondent data from the 1995-1997 National Health Survey
of Gulf War Veterans matched to the Department of Veterans Affairs-Department of Defense
Mortality Data Repository database to determine vital status and underlying causes of death
from 2000-2017. Prevalence estimates and rates of all-cause and cause-specific mortality for
survey respondents meeting criteria for GWI as defined by the CDC and Kansas definitions were
compared to those who did not meet these criteria, stratified by status of deployment to the
1990-1991 Gulf War (deployed and non-deployed). Indirectly age- and gender-adjusted
standardized mortality rate ratios and adjusted hazard ratios were calculated for comparisons
between deployed and non-deployed veterans with and without symptoms meeting criteria for
GWI.
Results: Deployed veterans meeting criteria for GWI in 1995-1997 were at increased risk for
cause-specific mortality due to malignant neoplasms, circulatory system disorders, and
digestive system disorders, and had greater risk for overall mortality compared to deployed
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veterans who did not meet criteria for GWI. However, when compared to non-deployed
veterans with probable GWI, deployed veterans with probable GWI had decreased overall
mortality risk and decreased risk for mortality due to diseases of the circulatory system.
Conclusion: To the best of our knowledge, this is the first study to assess mortality status and
cause-specific risk of death among veterans meeting criteria for GWI. These results may aid in
development of a more precise definition of GWI.
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Introduction
The mortality status and characteristics of veterans deployed to the 1990-1991 Persian Gulf
War have been reported in several publications, though research on mortality findings specific
to veterans with probable Gulf War Illness (GWI) is lacking [1-3]. Previous studies have shown
that deployment to the Gulf War is not associated with overall increased risk of death
compared to those who served in the military during the same time period but did not deploy
to the Persian Gulf region, though overall mortality risk is 15% greater among females when
stratified by gender [1].

Several studies have reported increased risk of death due to external causes among deployed
Gulf War veterans compared to veterans who were not deployed to the 1990-1991 Gulf War
(non-deployed) [1,3]. One population-based study of veterans who served in the Gulf War
found an increased risk of death due to brain cancer among a subgroup of deployed veterans
with suspected exposure to sarin gas at the explosion of the Khamisiyah munitions cache or oil
well fire smoke [2], though risk for brain cancer mortality dissipated over time [4]. In a 13-year
follow-up study, Army Gulf War veterans thought to have exposure at Khamisiyah were three
times more likely to die from cirrhosis of the liver compared to Army veterans who did not
deploy [1]. Compared to the U.S population, female deployed Gulf War veterans were 60%
more likely to die by suicide, while male veterans were less likely when compared to males in
the U.S. population at 13-years post-war follow-up [1].
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Significant numbers of veterans returning from service in the 1990-1991 Gulf War reported a
difficult to diagnose syndrome of illnesses characterized by various combinations of
neurological and cognitive disorders, pain, fatigue, musculoskeletal issues, gastrointestinal
problems, and respiratory illnesses [5]. This group of conditions, currently referred to as GWI, is
estimated to occur in 25-40% of veterans who deployed to the 1990-1991 Persian Gulf War [6]
[12]. While no universal case definition exists, two definitions are commonly used to define
GWI and supported by recommendations from a 2014 Institute of Medicine (IOM) report [5]: 1)
a definition developed by Fukuda, et al. [7], commonly referred to as the Centers for Disease
Control (CDC) definition; and 2) a definition developed by Steele [8], commonly referred to as
the Kansas definition.

Criteria for the CDC definition of GWI include experiencing at least one medical condition or
symptom occurring for the first time after the 1990-1991 Persian Gulf War in two of the three
domains of fatigue, mood and cognitive disorders, and musculoskeletal problems; no exclusion
criteria limit eligibility for GWI according to this definition [7]. To meet the criteria of GWI
according to the Kansas definition, a veteran must have medical conditions occurring for the
first time after the 1990-1991 Persian Gulf War in three of the following six domains: fatigue,
pain, neurological/mood/cognition, gastrointestinal, respiratory, and skin disorders. Veterans
experiencing serious psychiatric conditions or diagnosis of serious health conditions including
cancer, diabetes, infectious disease, heart disease, stroke, liver disease, lupus, multiple
sclerosis, and problems resulting from postwar injuries are excluded from eligibility for GWI
according to the Kansas definition [8]. No studies have validated either the CDC or Kansas
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definitions of GWI, yet both are commonly used to determine probable GWI classification.
Recently, the IOM expressed need for development of a more robust GWI case definition [5].

Given the multiple bodily systems related to and impacted by GWI, we expect to find increased
risk of death due to GWI-related diseases among veterans with probable GWI compared to
those without similar symptoms. A historical cohort of veterans meeting GWI criteria in the
early years after the war provides a unique opportunity to investigate long-term mortality
outcomes associated with GWI [6]. The purpose of this study is to characterize patterns of
mortality among veterans with evidence of GWI and compare all-cause and cause-specific
mortality rates to those of veterans without early evidence of GWI. We hypothesize that
deployed veterans who meet criteria for GWI will have significantly greater risk for all-cause
and cause-specific mortality.

Methods
Measures
Data for this study come from the 1995-1997 NHS [27] and the Joint Department of Defense –
Department of Veterans Affairs Mortality Data Repository (MDR) [10]. Demographic variables
from the NHS included age group, gender, and race/ethnicity. The NHS data was used to
identify veterans meeting criteria for GWI according to both accepted definitions [7, 8]. Details
about how these definitions were applied to NHS data can be found in a previous publication
[6]. For these current analyses, we define probable GWI as any survey respondent meeting
criteria for either the CDC or Kansas definition and negative for probable GWI as those veteran
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respondents who did not meet criteria for either definition at the time of survey completion.
Since a significant number of non-deployed veteran respondents to the NHS met criteria for
GWI, comparison groups for these analyses are stratified by deployment status and probable
GWI status.

We included all four groups (deployed and non-deployed, with and without probable GWI) for
comparisons in our analyses in order to evaluate possibility of a dose-response mortality
relationship. We assessed for increased risk for death due to diseases not already included in
GWI definition domains, which may indicate need for inclusion of additional conditions in an
updated GWI definition. A lack of differences between these four comparison groups may be an
indication of poor specificity of the CDC and/or Kansas definitions; meaning these definitions
may capture large numbers of false positives.

Mortality data for these analyses come from the MDR, a database containing mortality
information for all deceased veterans of military service for the years 1979-2017. The MDR is a
combination of multiple federal databases including the National Death Index, Department of
Defense databases, and Veterans Health Administration files. The MDR includes information on
all deaths, including specific causes of death, using ICD-9 and ICD-10 codes [10] . Using social
security numbers, veteran respondents to the NHS were matched to MDR records from 20002017 to determine vital status and underlying cause of death for those who were deceased.
Mortality results are reported using ICD-10 classifications [11].
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Statistical analyses
We calculated prevalence estimates and mortality rates per 1,000 person-years for respondents
with and without probable GWI, stratified by status of deployment to the 1990-1991 Persian
Gulf War (deployed and non-deployed). Due to small cell counts, mortality results are
presented in collapsed ICD-10 categories [11]. Indirectly age- and gender-adjusted standardized
mortality rate ratios and 95% confidence intervals were calculated for ICD-10 collapsed
categories for comparisons between deployed and non-deployed veterans with and without
symptoms meeting criteria for GWI. Cox proportional hazard models were calculated for
estimating risk of death among the comparison groups, adjusted for gender, age group, and
race/ethnicity. Standardized mortality rate ratios and Cox proportional hazard models were
applied to seven sets of comparisons:
-Deployed compared to non-deployed (1)
-Deployed with probable GWI compared to:
Deployed without probable GWI (2)
Non-deployed without probable GWI (3)
Non-deployed with probable GWI (4)
-Non-deployed with probable GWI compared to:
Non-deployed without probable GWI (5)
Deployed without probable GWI (6)
-Deployed without probable GWI compared to non-deployed without probable GWI (7)
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Data were analyzed using SAS Enterprise Grid software (version 5.1, SAS Institute, Inc.). Alpha
was set at 0.05 for all analyses.

Results
Table 1 presents mortality incidence and rates for collapsed ICD-10 groups. Within the
deployed veteran group, the overall mortality rate was 3.61 per 1,000 person-years among
those meeting criteria for GWI and 2.80 among those who did not meet criteria for GWI. In the
non-deployed group, overall mortality was 4.49 per 1,000 person-years among those meeting
criteria for GWI and 3.45 among those not meeting GWI criteria. Deaths due to malignant
neoplasms (ICD-10 category C00-C97) were highest among all categories for deployed veterans
with and without probable GWI (1.25 per 1,000 person years and 0.82 per 1,000 person years,
respectively). The highest rate of cause-specific mortality was for diseases of the circulatory
system (ICD-10 I00-I99) (1.40 per 1,000 person-years) among the non-deployed group meeting
criteria for GWI. Among the deployed group meeting criteria for GWI, deaths due to diseases of
the nervous system (ICD-10 G00-G09) were lowest of all cause-specific death categories in this
group (0.09 deaths per 1,000 person-years).

Total deployed compared to total non-deployed veterans
As shown in Table 2, deployed veterans had statistically significantly reduced risk of all-cause
mortality compared to non-deployed veterans (standardized mortality ratio (SMR) = 0.89, 95%
confidence interval (CI) = 0.85, 0.99). When stratified by gender, female deployed veterans had
a 26% reduced risk of overall mortality compared to non-deployed females (SMR = 0.74, 95% CI
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= 0.57, 0.96); there was no statistically significant difference in overall mortality among males
(Table 2). When controlling for gender, age, and race/ethnicity, there was no increased risk of
all-cause or cause-specific mortality among the deployed compared to non-deployed veterans
(Table 3).

Deployed veterans had an increased risk of death due to accidental injury (SMR= 1.48, 95% CI =
1.05, 2.10), which remained significant among males (SMR=1.57, 95% CI = 1.03, 2.43) but not
females when stratified by gender (Table 2). Deployed veterans had lower risk of mortality due
to malignant neoplasms (SMR = 0.83, 95% CI = 0.72, 0.95) and diseases of the circulatory
system (SMR = 0.84, 95% CI = 0.71, 0.98) compared to non-deployed veterans (Table 2). When
controlling for gender, age, and race/ethnicity in the Cox proportional hazards models, there
was decreased risk for deaths due to malignant neoplasms among all deployed compared to all
non-deployed veterans (aHR = 0.73, 95% CI = 0.54, 0.99) (Table 3).

Deployed veterans with probable GWI compared to deployed veterans without probable GWI
Deployed veterans who met criteria for GWI had a greater risk of all-cause mortality compared
to deployed veterans without probable GWI (SMR = 1.28, 95% CI = 1.05, 1.28) (Table 2). This
finding remained statitstically significant when controlling for gender, age, and race/ethnicity in
Cox proportional hazard models (aHR= 1.30, 95% CI = 1.10, 1.55) (Table 3). When stratified by
gender, female deployed veterans with probable GWI were nearly twice as likely to die from
any cause compared to those without probable GWI (SMR = 1.90, 95% CI = 1.42, 2.53) (Table 2).
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Deployed males with probable GWI had 26% increased risk for all-cause mortality compared to
deployed males without GWI (SMR = 1.26, 95% CI = 1.02, 1.28) (Table 2).

Among the cause-specific mortality categories, compared to deployed veterans not meeting
GWI criteria, deployed veterans with probable GWI were at increased risk for malignant
neoplasms (SMR = 1.53, 95% CI = 1.30, 1.81), diseases of the circulatory system (SMR = 1.51,
95% CI = 1.24, 1.82), and diseases of the digestive system (SMR = 3.15, 95% CI = 2.04, 4.89)
(Table 2). When controlling for all demographic covariates in the Cox proportional hazards
models, these findings remain statistically significant. Deployed veterans with probable GWI
were at increased risk for death due to malignant neoplasms (adjusted hazard ratio (aHR) =
1.53, 95% CI = 1.12, 2.10), diseases of the circulatory system (aHR = 1.54, 95% CI = 1.08, 2.20),
and diseases of the digestive system (aHR = 3.16, 95% CI = 1.08, 2.20) compared to deployed
veterans without probable GWI (Table 3).

Deployed veterans with probable GWI compared to non-deployed veterans without probable
GWI
Compared to non-deployed veterans without probable GWI, deployed veterans with probable
GWI were at increased risk for overall death when controlling for covariates (aHR = 1.17, 95% CI
= 1.02, 1.35) (Table 3). Deployed veterans with probable GWI were at increased risk for death
due to accidental injury (SMR = 1.98, 95% CI = 1.27, 2.95) compared to non-deployed veterans
without probable GWI (Table 2). When controlling for all demographic covariates in Cox
proportional hazard models, deployed veterans with probable GWI were at increased risk for
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death due to other external causes of accidental injury (aHR =2.21, 95% CI = 1.09, 4.48) and
accidental poisoning by exposure to noxious substances (aHR = 11.19, 95% CI = 1.43, 87.62)
compared to non-deployed without probable GWI (Table 3).

Deployed veterans with probable GWI compared to non-deployed veterans with probable GWI
Among all respondents meeting criteria for GWI, deployed veterans had lower risk for all-cause
mortality when compared to non-deployed veterans (SMR = 0.80, 95% CI = 0.73, 0.89) (Table 2),
(aHR = 0.83, 95% CI = 0.69, 0.99) (Table 3). Veterans who were deployed with probable GWI
had lower risk of death due to diseases of the circulatory system (aHR = 0.71, 95% CI = 0.51,
0.99) compared to non-deployed veterans with probable GWI (Table 3).

Among males who met the criteria for GWI, those who were deployed had greater risk of death
due to neurological diseases (SMR = 2.42, 95% CI = 1.21, 4.83) (Table 2) and lower risk of death
due to endocrine, nutritional, and metabolic diseases (SMR = 0.51, 95% CI = 0.29, 0.90) and
diseases of the circulatory system (SMR = 0.70, 95% CI = 0.57, 0.86) compared to non-deployed
males (Table 2).

Non-deployed veterans with probable GWI compared to non-deployed veterans without
probable GWI
Within the non-deployed group, veterans who met criteria for GWI had greater risk of death
overall compared to those without probable GWI (SMR = 1.30, 95% CI = 1.12, 1.51) (Table 2),
(aHR = 1.40, 95% CI = 1.17, 1.68) (Table 3). Compared to non-deployed without probable GWI,
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non-deployed with probable GWI were at increased risk for accidental poisoning by and
exposure to noxious substances compared to non-deployed veterans without GWI, though the
confidence intervals were unreliable and skewed due to small numbers (aHR = 15.23, 95% CI =
1.77, 131.22) (Table 3).

Non-deployed veterans with probable GWI compared to deployed veterans without probable
GWI
Non-deployed veterans who met criteria for GWI had greater risk of death overall compared to
deployed without probable GWI (SMR = 1.60, 95% CI = 1.25, 1.68) (Table 2). This finding
remained statistically significant when controlling for all demographic covariates in Cox
proportional hazard models (aHR = 1.57, 95% CI = 1.27, 1.93) (Table 3).

Deployed veterans without probable GWI compared to non-deployed veterans without probable
GWI
Among all veterans who did not meet criteria for GWI, deployed veterans GWI had lower risk of
death due to malignant neoplasms (SMR = 0.63, 95% CI = 0.48, 0.82) and diseases of the
circulatory system (SMR = 0.73, 95% CI = 0.54, 0.98) compared to non-deployed (Table 2). In the
gender-stratified models, deployed males without probable GWI had greater risk of death due
to intentional self-harm (SMR = 1.95, 95% CI = 1.16, 3.30) compared to non-deployed males
without probable GWI.
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Conclusion
Overall, we found a 30% increased mortality risk among deployed veterans who met the criteria
for either the CDC or Kansas definition for GWI in 1995-1997 compared to deployed veterans
who did not meet criteria for probable GWI. However, among all respondents with probable
GWI, deployed veterans had 17% decreased risk for overall mortality compared to nondeployed respondents. We found evidence to support our hypothesis of an increased risk for
mortality among deployed veterans meeting criteria for GWI compared to the other groups
given the myriad of symptoms and disorders associated with GWI. Interestingly, our results
show non-deployed veterans meeting criteria for GWI to be at greater risk of overall mortality
when compared to deployed veterans with GWI, deployed veterans without GWI, and nondeployed veterans without GWI.

Our results comparing all deployed to non-deployed indicated decreased risk for all-cause and
cause-specific mortality due to malignant neoplasms and diseases of the circulatory system,
regardless of probable GWI classification. A previous study of Gulf War era veterans found no
statistically significant differences in overall mortality, mortality due to malignant neoplasms, or
diseases of the circulatory when comparing deployed to non-deployed at 13 years post-war [1].

Within the deployed group, comparing those with probable GWI to those without, we found
increased risk of mortality due to malignant neoplasms, diseases of the digestive system, and
diseases of the circulatory system. Digestive system illnesses are included as a domain for the
Kansas GWI criteria, so increased mortality related to these disorders is predictable and does

63

support our hypothesis for increased risk of death due to domain related illnesses. However,
increased risk of death due to malignant neoplasms and circulatory system diseases are notable
as these symptoms are not included as criteria for the CDC or Kansas definition of GWI and are
part of the exclusion criteria for the Kansas definition. When looking at the non-deployed
group, those with probable GWI had increased risk of all-cause mortality and mortality due to
diseases of the circulatory system compared to those without probable GWI, a similar finding to
the same comparison in the deployed group. A possible explanation for these findings is that
veterans who met the criteria for GWI are more likely to have reported pre-war medical
conditions, including cardiac problems such as coronary heart disease, hypertension, and
tachycardia (Aim One findings, results not published). Veterans meeting the criteria for GWI
also were more likely to have reported genitourinary, pain, neurological, and respiratory
disorders, which taken together could indicate poorer baseline health and increased risk for
premature mortality (Aim One findings, results not published).

Among all veterans meeting criteria for probable GWI, those in the deployed group had
statistically significantly reduced risk of overall mortality compared to non-deployed when
controlling for gender, age, and race/ethnicity, an unexpected finding given that the deployed
group experienced exposure to hazards of the Gulf War, which we speculated would put them
at greater risk for poorer future health and related mortality outcomes. One possible
explanation for this finding is that perhaps healthier servicemembers were chosen for Gulf War
deployment. Several mortality studies of deployed and non-deployed Gulf War veterans have
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demonstrated that the deployed group was at lower risk for mortality compared to nondeployed veterans [1-3].

We found some support for our hypothesis that respondents meeting the criteria for GWI in
1995-1997 would have increased risk of domain-related cause-specific mortality compared to
those without probable GWI between the years 2000-2017. Deployed males with probable GWI
had increased risk of death due to nervous system diseases compared to non-deployed with
probable GWI; neurological symptoms were included as domains in the Kansas definition of
GWI. However, when controlling for gender, age, and race/ethnicity in Cox proportional hazard
models, there was no increased risk of mortality in any comparison group. Among all
comparisons, we found no increased risk of mortality due to diseases of the respiratory system
when controlling for all demographic covariates, which does not support our hypothesis of
greater risk for mortality due to domain-related diseases among those with probable GWI as
respiratory disease is a domain included in the Kansas GWI definition. As mentioned above, we
found increased risk of mortality due to digestive diseases, a domain included in the Kansas
GWI definition, among the those with probable GWI compared to those without for both the
non-deployed and deployed subgroups, when controlling for demographic covariates.

We found evidence for increased risk of mortality for two groups of medical conditions not
directly related to the CDC or Kansas GWI definition domains – endocrine, nutritional, and
metabolic diseases and circulatory system diseases. Deployed males with probable GWI had
lower risk of death due to endocrine, nutritional, and metabolic diseases compared to non-
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deployed with probable GWI, a finding unsupportive of the recent interest in the expected
positive relationship between metabolic syndrome and GWI [12, 13] . While endocrine,
nutritional, and metabolic diseases are correlated with obesity, a study of Gulf War deployed
and non-deployed veterans in 2003-2005 did not find any differences in obesity between these
two groups [14]. Results from the Millennium Cohort Study reported greater prevalence of
obesity among military servicemembers and veterans who did not deploy, though this data is
not limited to Gulf War veterans [15].

Our findings show increased risk for diseases of the circulatory system among deployed
veterans with probable GWI versus deployed without probable GWI, and non-deployed
veterans with probable GWI compared to all other groups. A recent study demonstrated that
cardiac symptoms reported pre-Gulf War predicted probable GWI at 5 years post-war (Aim One
findings, results not published), which could explain the increased risk for mortality due to
diseases of the circulatory system. This finding may also be partially explained by the inclusion
of pain as a domain for the Kansas GWI definition and musculoskeletal disorders as a domain
for the CDC GWI definition. Pain is positively related to inflammation [16], which studies have
shown is associated with heart disease [17]. Further research is needed to determine the
relationship between endocrine, nutritional, and metabolic diseases and diseases of the
circulatory system and GWI.

There are several limitations to this study. First, it is possible that some veteran respondents
who did not meet criteria for either the CDC or Kansas definitions for GWI on the NHS survey in
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1995-1997 may have developed symptoms later on that would classify they as having GWI,
resulting in misclassification bias. As mentioned earlier, neither the CDC nor the Kansas
definition of GWI have been validated and results from analyses using these two measures may
be prone to misclassification bias. Response bias may have influenced survey responses to the
NHS resulting in an overestimate of veterans meeting GWI criteria. Self-reported data is at risk
for recall bias, which may differ by deployment group. In this study, veterans who deployed and
were experiencing health effects may have had better recall of their time period of symptom
onset compared to those who were not deployed or not feeling ill. In our analyses we did not
include data on environmental exposures such as potential sarin gas exposures resulting from
the weapons cache destruction at Khamisiyah and oil well fire smoke. Additionally, we did not
assess for mortality trends over time. Using aggregated data could result in null findings at the
end of the follow up period and obscuration of significant mortality trends. These mortality
data were limited to 2000-2017 in order to look at long-term mortality follow-up of those who
had probable GWI in the early years after the war, though by doing so we may have overlooked
important mortality findings that occurred between 1995 and 2000; however, mortality
analyses published for deployed and non-deployed Gulf War veterans within this time frame
indicate low mortality overall and increased risk of death due to external causes among
deployed compared to non-deployed [3]. Our mortality results are grouped by ICD-10
categories due to small numbers, which may conceal disease-specific mortality relationships
associated with probable GWI. There are several strengths to this study. A population-based
sampling scheme was used for the NHS, allowing survey responses to more closely represent
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the larger deployed and non-deployed population. The large number of survey respondents and
70% response rate allowed for an adequate sample size for these analyses.

To our knowledge this is the first study to report the long-term mortality status of 1990-1991
Persian Gulf War veterans who met criteria for GWI. We found that veterans with probable
GWI were at greater risk of mortality overall, and specifically due to malignant neoplasms,
diseases of the circulatory system, and diseases of the digestive system compared to deployed
veterans not meeting GWI criteria, though mortality risk was decreased when compared to
non-deployed veterans with probable GWI. Our findings of increased risk of all-cause and
cause-specific mortality among non-deployed veterans with probable GWI adds to the
complexity associated with attempts to define this syndrome.

Examining the long-term mortality experience of veterans with early-onset GWI aids in our
understanding of the trajectory of the disorder. Veterans who are classified as having GWI
should be monitored for health conditions not directly to their GWI symptoms, such as cancers,
metabolic disorders, and cardiovascular disease.
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Assessing the risk of female-specific medical conditions among women with Gulf War Illness
Abstract
Introduction: Women comprise approximately 7% of the deployed Gulf War veteran cohort yet
research has shown that women have higher prevalence of Gulf War Illness (GWI) compared to
men. While several studies have demonstrated increased risk for female-related medical
conditions and adverse reproductive outcomes among women deployed to the Gulf War,
research on female-specific health outcomes specifically related to GWI is sparse. The objective
of this study is to assess the incidence and risk of female-specific medical conditions among
Gulf War veterans with and without probable GWI.
Methods: Deployed and non-deployed female veterans were identified using data from the
National Health Survey of Persian Gulf War Era Veterans, a population-based survey conducted
in 1995-1997. Respondents were classified as meeting criteria for GWI according to the CDC
and Kansas definitions and were matched to Department of Veterans Affairs electronic medical
records. Visits related to female-specific ICD-9 diagnoses were analyzed. We calculated
incidence, indirectly age-adjusted standardized incident rate ratios, and adjusted hazard ratios
using Cox proportional hazard models adjusting for race/ethnicity and age group.
Results: Deployed women meeting criteria for either the CDC or Kansas definition of GWI in
1995 were at increased risk for disorders of the breast and female genital tract compared to
non-deployed women who did not meet GWI criteria. Within the deployed group, women
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meeting criteria for GWI had increased risk for disorders of the female genital tract compared
to those not meeting GWI criteria.
Conclusion: Our findings show that there may be increased risk for female-specific medical
conditions among women who were deployed who met the criteria for GWI in 1995, however
additional research is needed to evaluate possible relationships between female-specific and
reproductive health outcomes and GWI.
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Introduction
Approximately 37,000 women servicemembers were deployed to the 1990-1991 Gulf War, the
largest deployment of women at the time, comprising nearly 7% of the total deployed
population [1]. A recent systematic review of epidemiologic studies on the health of Gulf War
veterans reported inconsistent findings in the limited published literature regarding the health
of women who deployed to the Gulf War [2]. Several studies have demonstrated that women
who deployed in support of the Gulf War were at increased risk for or reported high prevalence
of Gulf War Illness (GWI) symptomology, the signature illness of the Gulf War [3, 4]; however,
research on female-specific health outcomes related to GWI is sparse [2, 5]. Some studies have
reported inconclusive evidence that women Gulf War veterans were at increased risk for
reproductive issues and other health conditions [4, 6-12].

Research studies have demonstrated increased health concerns among women who were
deployed to the Gulf War in comparison to deployed men or non-deployed women. United
States (U.S.) Air Force Women who deployed to the Gulf War were more likely to report skin
rashes, coughing, unintentional weight loss, insomnia, depression, and memory problems two
to three years post Persian Gulf War deployment when compared to women who deployed to
other areas [13]. In a follow-up study of this same cohort, women deployed to the Persian Gulf
War reported more health problems, such as fatigue, joint pain, muscle pain or stiffness,
irritability, flu-like symptoms, and skin rash, compared to women deployed elsewhere [14]. A
survey of United Kingdom Air Force veterans reported that women had increased prevalence
and risk for some health conditions, including headaches, fatigue, pain, and loss of
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concentration compared to women not deployed and women deployed to Bosnia [4]. A study
completed 5 years post-war reported increased risk for outpatient medical visits and inpatient
hospital stays among deployed Gulf War women compared to deployed men [15]. A
population-based cross-sectional survey conducted in 2012-2014 reported increased risk for
migraines, irritable bowel syndrome, gastritis, endocrine disorders, asthma, tachycardia,
fibromyalgia, repeat bladder infections, and genital organ diseases among female deployed Gulf
War veterans when compared to male deployed veterans [16].

A few research studies have focused on female-specific health concerns among Gulf War
veterans, though results are inconsistent. A 1997 literature review and review of Gulf War
Health Registries of Gulf War investigated women’s health concerns and reported no significant
increased health risks [12]. Among the female-specific health conditions included in a survey of
United Kingdom Air Force veterans, deployed Gulf War women had greater risk of premenstrual
tension, period problems, yeast infections, and subfertility compared to women who deployed
to Bosnia [4]. A review study of reproductive outcomes among Gulf War women did not find
evidence for increased gynecological issues in deployed females compared to non-deployed
females [10].

Due to concerns about the potential for associations between negative reproductive health
outcomes and numerous environmental exposures during the Gulf War, several studies have
focused on birth defects, miscarriages, and fertility problems among deployed women
veterans. Results from a survey of United Kingdom (U.K.) Air Force veterans reported that Gulf
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War deployed women had greater risk for miscarriage compared to women who did not deploy
[4]. Results of a cross-sectional survey that collected data 5 years after the Gulf War
demonstrated higher prevalence of miscarriages in deployed females compared to their nondeployed counterparts, though the risk was not statistically significant [11]. A cross-sectional
survey conducted between 1998-2001 of Gulf War veterans from the U.K. reported no
increased risk for miscarriage among deployed females compared to female veterans who did
not deploy [9]. Review of the research on miscarriages in female deployed veterans found
some, though inconclusive, evidence of an association [10].

A 2006 review article summarizing the literature on Gulf War service and reproductive health
reported there was no consistent evidence for an association between deployment and birth
defects or fetal deaths, though results were limited by the small number of female study
participants [10]. One study found no increased risk for birth defects in babies born between
1998 and 2004 to men and women who deployed to the Gulf War compared to those who did
not deploy [6]. This same study reported increased risk for birth defects among deployed
women compared to non-deployed women [11]. One study found increased risk for
spontaneous abortions and ectopic pregnancies among deployed Gulf War women compared
to non-deployed women [8]. A study of birth certificates of babies born to Gulf War deployed
and non-deployed women found increased risk for hypospadias among babies born post-war to
deployed Gulf War women compared to non-deployed [7]. However, many studies on fertility
among Gulf War women lacked statistical power for reaching conclusions [10].

79

Several research studies indicate that women veterans who deployed in support of the Gulf
War are more likely to meet the criteria for GWI compared to non-deployed women or
deployed men, though the reason for this difference is unknown. GWI, a syndromic disorder, is
the most concerning health outcome of the 1990-1991 Gulf War. Research studies have
identified common groups of symptoms occurring disproportionately in veterans of the Gulf
War compared to those who weren’t deployed, including fatigue, pain, neurological and
cognitive disorders, respiratory disorders, gastrointestinal issues, and dermatologic concerns. A
recent study that calculated prevalence of probable GWI using data from a 1995-1997
population-based survey of Gulf War veterans reported the prevalence among women at 4458% compared to 40-49% among men, depending on the definition of GWI used [17]. The
Millennium Cohort Study reported increased odds of chronic GWI among women who deployed
to the Gulf War compared to men, measured between years 2001-2008 [18]. A study of Gulf
War deployed Army servicemembers reported that 60% of women met the criteria for GWI,
and women were at increased risk for probable GWI compared to men [19]. Women veterans
from the United Kingdom Air Force deployed to the Gulf War had a greater than two-fold
increased risk for meeting the CDC definition of GWI compared to women deployed to Bosnia
and women who did not deploy [4]. There is some evidence that women deployed to the more
recent conflicts, Operation Enduring Freedom/Operation Iraqi Freedom, were at increased risk
for reporting medical conditions consistent with GWI compared to deployed men [20].
Research has shown that women are at greater risk for syndromic disorders, such as chronic
fatigue syndrome, fibromyalgia, and irritable bowel syndrome compared to men, which may
also explain the increased prevalence of GWI among women[21-25].
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Given the findings from previous studies indicating that women are disproportionately
impacted by GWI as well as the numerous studies indicating possible increased risk for femalespecific health concerns and reproductive outcomes among women who deployed to the Gulf
War, we hypothesize that women who were deployed to the Persian Gulf War who met criteria
for GWI will have higher incidence for reproductive disorders. In this study we assessed the risk
for female-specific medical conditions using Department of Veterans Affairs (VA) medical
record data from 2000-2014 among female Gulf War veterans who presented with symptoms
consistent with GWI in 1995-1997 compared to those without GWI symptomology. The
objective of this study is to assess the incidence of female-specific medical conditions among
Gulf War veterans meeting criteria of GWI compared to those who do not meet GWI criteria.

Methods
Women veterans included in this study were identified using respondent data from the 19951997 National Health Survey of Persian Gulf War Era Veterans (NHS) [26], a population-based
health survey of 15,000 veterans deployed to the 1990-1991 Gulf War and a comparison group
of 15,000 non-deployed veterans. Women were oversampled by 20%. The response rate was
approximately 70%, resulting in 20,917 respondents, of which 20% were women (n=4,208).
Detailed information regarding the NHS has been reported previously [26].

Measures
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Gender, age (grouped based on age at end of follow-up), and race/ethnicity (white, nonHispanic vs. other) were self-reported on the NHS. Deployment status was determined by the
Department of Defense’s Defense Manpower Data Center, which provided military
servicemember identities for the NHS cohort.

For this study GWI status was determined by applying existing definition criteria to responses to
medical conditions and symptoms on the NHS. In 2014, the Institute of Medicine (IOM)
reviewed all published studies attempting to define GWI [27]. They concluded that an ideal case
definition has yet to be developed and tested, and recommended use of two existing
definitions: the definition developed by the Centers for Disease Control and Prevention, known
as the CDC definition [28], and another version developed using a Kansas-based veteran cohort,
referred to as the Kansas definition of GWI [29]. Neither of these definitions have been
validated or tested for reliability [27]. Recently, the criteria for determining a GWI case using
the CDC and Kansas versions were applied to the historical NHS data. Detailed information
about these methods are available in a previous publication [17]. In the NHS study, 43.9% of
deployed women met the criteria for the Kansas definition of GWI while 58.2% met the criteria
for GWI according to the CDC definition [17]. For this current study, female veterans who met
the criteria for either the CDC or the Kansas definitions for GWI were classified as positive for
probable GWI, while those who did not meet either criteria were classified as negative [28, 29].

Social security numbers of female veterans who were not missing a CDC or Kansas GWI
classification (n=3,988) were matched to the VA Corporate Data Warehouse, the electronic
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medical record database for years 2000 through 2014 including inpatient, outpatient,
emergency department visits, and fee for service files. Of the female NHS respondents, 51% (n=
2,049) had at least one VA medical record. For these analyses, we limited records to the earliest
occurrence of female-specific medical conditions for each social security number using ICD-9
codes [30].

Statistical Analyses
We calculated incidence, person years at risk, crude incidence rates per 1,000 person-years,
and indirectly age-adjusted standardized incidence rates per 1,000 person-years of femalespecific medical conditions stratified by deployed veterans with and without GWI, and
nondeployed veterans without GWI. Indirectly age-adjusted standardized incidence rate ratios
(SIR) and 95% confidence intervals (CI) for female-related medical conditions were calculated
for collapsed ICD-9 categories and expanded three-digit ICD-9 codes with sufficient numbers of
cases. Person-years were counted starting with the veteran’s first visit. Veterans were censored
from the denominator if deceased or if two years lapsed without an additional medical visit.
Cox proportional hazard models controlling for race/ethnicity and age group were used to
calculate adjusted hazard ratios (aHR) and 95% confidence intervals (CI) for female-specific
medical conditions for collapsed ICD-9 categories and selected three-digit ICD-9 codes with
sufficient number of cases.

Three sets of comparisons were made for each analyses: deployed with GWI compared to nondeployed without GWI, deployed with GWI compared to deployed without GWI, and deployed
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without GWI compared to non-deployed without GWI, the latter to get a sense of the
underlying or baseline rates of female medical conditions in the deployed group compared to
the non-deployed group. Data were analyzed using SAS Enterprise Grid software (version 5.1,
SAS Institute, Inc.). Alpha was set at 0.05 for all analyses.

Results
Table 1 presents the incidence, crude incidence rate ratios per 1,000 person-years, and
indirectly age-adjusted standardized incident rate ratios (SIR) of female-specific ICD-9
categories (disorders of breast; inflammatory disease of female pelvic organs; other disorders
of female genital tract; complications of pregnancy, childbirth, and the puerperium; certain
conditions originating in the perinatal period) among female veteran respondents to the NHS
stratified by deployment and GWI status. The conditions with the greatest incidence rates were
disorders of the breast (ICD-9 610-612) and other disorders of the female genital tract (ICD-9
617-629) for each deployment and GWI category. Deployed women meeting criteria for GWI
were more likely to report a disorder of the breast (SIR = 1.23, 95% CI = 1.08, 1.40) and other
disorders of the female genital tract (SIR = 1.28, 95% CI = 1.17, 1.41) compared to non-deployed
women without GWI. Compared to deployed women not meeting the criteria for GWI,
deployed women with GWI had 27% increased risk for a disorder of the female genital tract (SIR
= 1.27, 95% CI = 1.16, 1.39).

Table 2 presents incidence, crude incident rate ratios, and indirectly age-adjusted standardized
incidence rate ratios for expanded ICD-9 categories. For all three stratification groups, incidence

84

was greatest for ICD-9 627, menopausal and postmenopausal disorders. Compared to nondeployed women who did not meet the criteria for GWI, deployed women who met the criteria
for GWI in 1995 were more likely to have a VA medical visit for other disorders of the breast
(SIR = 1.18, 95% CI = 1.03, 1.36); inflammatory disease of cervix, vagina, and vulva (SIR = 1.20,
95% CI = 1.04, 1.39); genital prolapse (SIR = 1.53, 95% CI = 1.09, 2.16); noninflammatory
disorders of cervix (SIR = 1.38, 95% CI = 1.07, 1.77); noninflammatory disorders of vagina (SIR =
1.91, 95% CI = 1.56, 2.34); pain and other symptoms associated with female genital organs (SIR
= 1.24, 95% CI = 1.07, 1.45); disorders of menstruation and other abnormal bleeding from
female genital tract (SIR = 1.24, 95% CI = 1.09, 1.42); menopausal and postmenopausal
disorders (SIR = 1.39, 95% CI = 1.23, 1.58). Deployed women meeting GWI criteria were at
increased risk for the following medical conditions compared to deployed women without GWI
symptoms: inflammatory disease of cervix, vagina, and vulva (SIR = 1.22, 95% CI= 1.05, 1.41);
endometriosis (SIR = 1.82, 95% CI = 1.31, 2.58); noninflammatory disorders of ovary, fallopian
tube, and broad ligament (SIR = 1.62, 95% CI = 1.27, 2.06); noninflammatory disorders of vagina
(SIR = 1.67, 95% CI =1.36, 2.04); pain and other symptoms associated with female genital organs
(SIR =1.19, 95% CI = 1.03, 1.37); disorders of menstruation and other abnormal bleeding from
female genital tract (SIR = 1.53, 95% CI = 1.33, 1.75).

Deployed veterans who met the criteria for GWI in 1995 were also at increased risk for several
female specific medical conditions compared to deployed veterans who did not meet criteria
for GWI (Table 2). Deployed veterans who met the criteria for GWI were at increased risk for
inflammatory disease of cervix, vagina, and vulva (SIR = 1.22 , 95% CI = 1.05, 1.41);
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endometriosis (SIR = 1.82, 95% CI = 1.31, 2.58); genital prolapse (SIR = 1.42, 95% CI = 1.01,
1.99); noninflammatory disorders of ovary fallopian tube and broad ligament (SIR = 1.62, 95% CI
= 1.27, 2.06); noninflammatory disorders of vagina (SIR = 1.67, 95% CI =1.36, 2.04); pain and
other symptoms associated with female genital organs (SIR = 1.19, 95% CI = 1.03, 1.37); and
disorders of menstruation and other abnormal bleeding from female genital tract (SIR = 1.53,
95% CI = 1.33, 1.75). When comparing deployed and non-deployed veterans without probable
GWI, women who were deployed were at decreased risk for noninflammatory disorders of
ovary, fallopian tube, and broad ligament (SIR = 0.53, 95% CI = 0.33, 0.97). Deployed women
who did not meet criteria for GWI were at increased risk for noninflammatory disorders of
vagina (SIR = 1.76, 95% CI = 1.21, 2.55) and menopausal and postmenopausal disorders (SIR =
1.30, 95% CI = 1.04, 1.63) compared to non-deployed who did not meet the criteria for GWI.
Incidence estimates were too small for calculating SIRs for the expanded list of conditions in the
complications of pregnancy, childbirth, and the puerperium ICD-9 category.

Table 3 presents the adjusted hazard ratios (aHR) resulting from Cox proportional hazards
models which control for age and race/ethnicity for the collapsed ICD-9 groups of femalespecific medical conditions. The only statistically significant result was an increased risk for
disorders of the female genital tract for deployed veterans who met the criteria for GWI when
compared to non-deployed veterans who did not meet the criteria for GWI (aHR = 1.24, 95% CI
= 1.06, 1.47).
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Table 4 shows adjusted hazard ratios for the expanded list of ICD-9 codes for the other
disorders of female genital tract category. Deployed veterans who met the criteria for GWI had
a marginally significant increased risk for menopausal and postmenopausal disorders compared
to non-deployed veterans who did not meet criteria for GWI when controlling for age and
race/ethnicity (aHR=1.26, 95% CI = 1.002, 1.59). Among those without GWI symptoms,
deployed women were at 44% increased risk for disorders of menstruation and other abnormal
bleeding from female genital tract compared to non-deployed, controlling for age and
race/ethnicity (aHR = 1.44, 95% CI = 1.04, 1.98).

Conclusion
Results of our study show that women veterans who were deployed in service of the 1990-1991
Gulf War who met the criteria for GWI were at increased risk for some female-specific medical
conditions at 9 to 24 years follow-up. Deployed women meeting criteria for either the CDC or
Kansas definition of GWI in 1995 were at increased risk for disorders of the breast and female
genital tract compared to non-deployed women who did not meet GWI criteria. Within the
deployed group, women meeting the criteria for GWI had increased risk for disorders of the
female genital tract compared to those not meeting GWI criteria.

To our knowledge, this is the first study to look at female-specific health outcomes among
women meeting criteria for GWI. Results of previous research studies on female-specific
disorders among women deployed to the Gulf War have been inconsistent or underpowered,
with one study reporting increased risk for female-specific issues in a specific group of deployed
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women from the U.K. [4], and another study of U.S. women showing no increased risk for
gynecological issues [10]. Our results indicate deployed women without GWI criteria had no
increased risk in female-specific disorders compared to non-deployed without GWI. However,
our results indicate deployed women meeting criteria for GWI had increased risk for femalespecific disorders compared to both comparison groups: non-deployed women meeting criteria
for GWI and deployed women without GWI symptoms.

Previous research studies on reproductive issues among deployed women veterans showed
some increased risk for negative reproductive outcomes, including birth defects and
miscarriages, among deployed Gulf War women. Our findings do not support this finding,
though the number of visits for services related to complications of pregnancy, childbirth, and
the puerperium (ICD-9 630-679) and conditions originating in the perinatal period (ICD-9 760779) were small, and standardized incidence rate ratios and adjusted hazard ratios could not be
calculated.

Our findings indicate that women who met the criteria for GWI in 1995 experienced increased
risk for some female-specific disorders approximately 9 to 24 years after the Gulf War. These
findings indicate that women who served in the Gulf War may have experienced exposures
during deployment that could have put them at risk for increased female-specific health
conditions in addition to probable GWI symptoms.
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Studies of deployed women indicate women frequently experience gynecologic disorders
during deployment, often due to vaginal or urinary infections and menstrual disorders [31].
Conditions during deployment are associated with these disorders, such as heat, infrastructure,
and unsanitary environments [31]. A study of women military servicemembers who deployed to
the 1990-1991 Gulf War or other conflicts reported a change in feminine hygiene and
menstrual management practices between normal life and deployment [32]. A survey of
deployed women found that 30% experienced vaginal infections and 18% experienced urinary
tract infections [33].

Compared to their male counterparts, female military servicemembers are at increased risk for
experiencing military sexual trauma (MST), which is sexual assault or harassment experienced
during military service. Results of a population-based veteran survey reported 41% of women
and 4% of men met the criteria for MST [34]. Women who deployed or experienced combat are
at increased risk for military sexual trauma [35]. One study reported an association between
MST and liver disease among VA patients [36]. A study of women veterans reported increased
risk for reproductive and gynecological symptoms and urological issues, chronic fatigue, breast
disease, gastrointestinal, and cardiovascular disorders among those who reported MST
compared to those who did not [37].

Female-specific disorders can be caused by diseases of organs that effect the reproductive
system, including the thyroid, kidney, and liver [38]. Disorders of the genitourinary system were
found to be pre-war predictors of GWI in a previous study (Aim 1 results, data not published). It
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is possible that some women may have had pre-war health conditions related to femalespecific disorders that would have made them more likely to experience GWI symptoms.

Alternatively, meeting the criteria for GWI could be related to these increased female-related
health conditions. There is additional complexity in determining the relationship between GWI
symptomology and female-specific disorders due to the lack of a definitive case definition for
GWI. In their 2014 report, the IOM concluded that three domains of symptoms were
commonly found in all published attempts at GWI case definitions (fatigue, pain, and
neurocognitive dysfunction), with three additional domains found in all symptom-based studies
(respiratory, dermatologic, and gastrointestinal symptoms). While the CDC and Kansas versions
of GWI definitions are recommended as appropriate for research use [27], it is possible that
these two definitions are affected by low specificity due to the inclusion of additional and
different domains other than those concluded as most common by the IOM.

For our study, we identified women respondents on the survey who met criteria for either the
CDC or Kansas definitions, which included conditions such as headaches, joint pain, stomach or
abdominal pain, and excessive fatigue. It is possible that women who met these criteria may
have had increased risk for female-related health disorders due to an association between
female-related health outcomes and conditions included in the GWI domains. The lack of a
definitive case definition likely contributes to the inconsistent findings of female-specific health
outcomes related to Gulf War deployment and GWI.
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There are some limitations to this study. Survey results may be impacted by recall bias; ill
veterans may have been more likely to respond to the survey compared to veterans who were
not experiencing negative health. Additionally, not all veterans, regardless of deployment
status, are eligible for VA care, so medical records are limited to those that are eligible who
decided to use the VA medical system for health care. Some veterans may have deployed to
subsequent conflicts resulting in additional exposures. Additionally, some veterans who were
classified as not meeting GWI criteria in 1995 may have met the criteria for GWI in subsequent
years, resulting in potential misclassification of probable GWI status for the current study.

There are several strengths to this study. The NHS is a population-based survey that
oversampled women by 20% with a 70% response rate [26]. Due to the inclusion of a lengthy
list of medical conditions and symptoms, we were able to classify respondents as meeting
criteria for GWI according to the two currently recommended definitions of GWI, the CDC and
Kansas definitions. To our knowledge, this is the only existing survey available with deployed
and non-deployed GW veterans with the ability to classify according to probable GWI within 5
years post-war. Additionally, we were able to match the women survey respondents to
electronic VA medical records.

In conclusion, we found an increased risk for some female-related medical conditions in 2000
through 2014 among deployed women veterans who met criteria for either the CDC or Kansas
definitions of GWI. Specifically, these medical issues were mostly related to disorders of the
female genital tract. We found no increased risk for complications from pregnancy among
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deployed women with probable GWI. Our study findings underscore the need for an updated
and validated GWI definition. Without knowing the specificity of the CDC and Kansas definitions
of GWI, and without an alternative case definition or biomarker, we are unable to confirm GWI
cases. Without being able to confirm the true cases of GWI, we cannot be confident that our
findings represent a true relationship between GWI and female-specific health outcomes.
Determining an accurate case definition for GWI should be a priority in order to fully
understand the relationship between female-related health conditions and Gulf War
deployment and GWI.
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Chapter 5: Discussion
5.1 Summary
In the thirty years since the 1990-1991 Persian Gulf War, researchers have failed to agree on a
case definition for the proposed signature health outcome related to this military conflict, a
cluster of symptoms known as Gulf War Illness (GWI) [1]. The three research aims presented
sought to add greater understanding of GWI by examining pre-war medical conditions as
predictors of probable GWI, determining long-term mortality outcomes of veterans reporting
GWI symptoms, and investigating long-term risk for female-specific health visits among women
veterans with probable GWI. Additionally, because of the specificity and validity issues with the
two most common GWI definitions, we proposed an alternative definition for GWI based on
recommendations from the Institute of Medicine (IOM) [1].

5.1.1 Aim 1
Using population-based survey data collected in 1995, we discovered that deployed veterans’
self-reports of pre-war medical conditions and symptoms predict meeting criteria for GWI at a
later time point. For this study we used the IOM recommended CDC and Kansas definitions of
GWI, as well as a newly developed 3-domain version based on the IOM systematic literature
review conclusions [1-3]. The predictor groups included pain, dermatologic, genitourinary,
gastrointestinal, neurological, cardiac, respiratory, and inflammation, all of which
independently predicted probable GWI according to the CDC/Kansas and 3-domain definitions.
When included in the same logistic regression model, all predictor groups remained statistically
significant for both GWI classification methods. These results demonstrate that at least some
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veterans may have been pre-disposed to meeting GWI criteria, and that the number of pre-war
medical conditions and symptoms reported by veterans was associated with increased risk for
meeting GWI criteria. We conclude that pre-war predictors should be further explored and
potentially included in the criteria for a GWI case definition.

5.1.2 Aim 2
For the second aim, we calculated mortality risk among veteran survey respondents, classified
by probable GWI according to the CDC or Kansas definitions. Our findings indicate that among
deployed veterans, those meeting the CDC or Kansas criteria for GWI in 1995-1997 were at
increased risk for overall mortality and mortality due to malignant neoplasms, circulatory
system disorders, and digestive system disorders compared to those that did not report GWI
symptoms. Among veterans meeting GWI criteria, compared to non-deployed veterans,
deployed veterans have decreased risk of overall mortality and mortality due to diseases of the
circulatory system. It is worth noting that pre-war cardiac and gastrointestinal symptoms were
predictors of GWI as reported in Aim One of this dissertation.

5.1.3 Aim 3
For the third aim, we focused on health outcomes of deployed female veterans who met the
criteria for CDC or Kansas GWI, as research has shown that females have greater prevalence of
GWI compared to males [12]. Deployed women who met the criteria for GWI in 1995-1997
were more likely to have an electronic medical record visit for breast disorders or female
genital tract problems compared to women Gulf War era veterans who did not deploy and who
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did not have symptoms consistent with GWI. Among all deployed women, those meeting GWI
criteria were more likely to have disorders of the female genital tract compared to those
without GWI symptom criteria. The association may be partially explained by the increased risk
for meeting GWI criteria among veterans who had genitourinary symptoms pre-war, as
reported in Aim One.

There are some limitations to our findings, including those related to typical problems with
survey data such as self-report bias and missing data. There may be misclassification bias for
deployment status; some veterans may have had subsequent deployments or exposures after
the time of the survey. The most critical limitation is the constraints of using the CDC and
Kansas definitions of GWI to classify GWI. As mentioned previously, the studies that developed
the CDC and Kansas definitions used relatively small and non-generalizable samples and
resulting case definitions have not been validated [1-3]. Given the approximate 40-50%
prevalence of probable GWI according to these definitions among deployed veterans, and 17%
prevalence in the non-deployed group [4], it is likely that both versions have low specificity.
Without knowing if the case definition of GWI used is capturing true cases of GWI and excluding
non-cases, it is imprudent to make conclusions about our findings or those of other research
studies that use these case definitions.

5.2 Implications for future research
Our studies add to the large body of literature on GWI by reporting findings on previously
unknown characterization of GWI, specifically pre-war predictors, mortality outcomes, and
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female-specific health issues. These findings offer support for ongoing research towards a GWI
case definition. Our proposed, 3-domain version of GWI may be an improvement over the CDC
and Kansas definitions, but requires further replication studies and validity testing. Future
research studies should investigate the occurrence of GWI according to the CDC and Kansas
definitions, and any additional definitions of GWI that are worth pursuing, in the non-deployed
veteran population and general population in order to understand the prevalence of GWI
criteria in these populations and determine if this is, in fact, a unique disorder among Gulf War
veterans. Ultimately, the primary research focus in the area of GWI should be determining a
case definition.

5.3 Conclusion
Our results add to the vast literature on GWI; however, we cannot conclude from these studies
that GWI is a disorder unique to deployed veterans of the 1990-1991 Persian Gulf War. We
found that we were able to predict meeting the criteria for CDC or Kansas GWI with selfreported pre-war medical conditions and symptoms, which help explain our mortality and
female-specific results.

Findings from these three aims do not support use of the CDC or Kansas definitions of GWI as
recommended by the IOM. The IOM may have done the research and veteran community a
disservice by recommending use of these two case definitions due to lack of validation or
replication and overlap with other syndromic disorders. Continuing to conduct research studies
based on classifying veterans as having GWI using the CDC or Kansas definitions, without
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questioning the validity of these studies, is detrimental to Gulf War veterans who are
continuing to suffer from these complex symptom clusters.
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